SEC Filing Details

Document Details

Form
4
Filing Date
Nov 17, 2023
Document Date
Nov 1, 2023
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
Cumberland Pharmaceuticals, Inc.
Issuer
CUMBERLAND PHARMACEUTICALS INC